F44.7 F43.1 F60.3
Conditions
Interventions
Group 1: Baseline (neutral audiotape) 10 min
SUD, RSDI-SSD, saliva and blood samples (8 am)
Baseline (neutral audiotape) 10 min
facial mirror-confrontation 2 min
SUD, RSDI-SSD, saliva and blood samples
30 min later SUD, RSDI-SSD, saliva
60 min later SUD, RSDI-SSD, saliva, blood
discussion with qualitative interview (approx 30 min)
8 am following day: saliva sample
Sponsors
Universitätsklinikum Erlangen, Psychosomatische und Psychotherapeutische Abteilung
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Presence of PTSD or cPTSD and/or complex dissociative disorder and/or Borderline Personality Disorder
Exclusion criteria
Exclusion criteria: severe somatic or neurological disease, current severe depressive episode, current psychotic disorder, current substance abuse (abstinence since 3 months), intakte of betablockers, benzodiazepines or antiarrhythmic agents (because of psychophysiological measurements)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-reported stress/acute dissociation: Subjective Units of Disturbance (SUD-self-report scale, range 0-10)/Responses to Script-Driven Imagery Scale, subscale dissociation (RSDI-SSD questionnaire), each directly before and after facial mirror-confrontation and one hour after mirror-confrontation | — |
Secondary
| Measure | Time frame |
|---|---|
| logarithmus naturalis des Root Mean Square of Successive Differences (lnRMSSD); Pre-Ejection Period (PEP); Cortisol, DHEA, a-Amylase, Oxytocin, Prolactin, IL-1ß, IL-6, IFN-y,TNF-a; psychometric data; qualitative data from interview | — |
Countries
Germany
Contacts
Public ContactEva Schäflein
Universitätsklinikum ErlangenAbteilung für Psychosomatische Medizin und Psychotherapie
Outcome results
None listed